ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor is the companys most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.
| Registrars: |
Computershare Investor Services PLC |
| CFO: |
Ashley Clarke |
| Chairman and CEO: |
Timothy Paul McCarthy |
| Chief Operating Officer: |
Tim Franklin |
| Chief Science Officer: |
Sébastien Goudreau |
| Independent Non-Executive Director: |
Ketan Patel |
| Non-Executive Director: |
Lisa Baderoon |
| Senior Independent Non-Executive Director: |
Laurence Reilly |
| Address: |
One Bartholomew Close, London, United Kingdom |
| Phone: |
+44 20 7206 2650 |
| Fax: |
+44 20 7152 4001 |
| Website: |
http://www.immupharma.co.uk/ |
| Email: |
|